This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Alcala Pharmaceutical, Inc.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Innovations by Irfan Baig in Drug Analysis
Introduction
Irfan Baig is an accomplished inventor based in San Diego, CA, known for his significant contributions to the field of drug analysis. With a total of 2 patents, he has developed innovative methods that enhance the efficiency and accuracy of analyzing biological samples.
Latest Patents
Irfan Baig's latest patents include a "Method for preparation of dried blood sample for multiplexing of analytes" and a "Method for qualitative and quantitative multiplexing of drug analytes from biological samples." The first patent outlines a process that involves mixing an Internal Standard solution with a diluent, adding a dried blood sample, and sonicating the mixture. This method allows for the generation of dried blood samples using minimal blood volume, which is crucial for efficient testing. The second patent focuses on analyzing drug analytes from dried blood samples, utilizing advanced techniques such as LC-MS and LC-MS/MS to determine the presence of multiple analytes simultaneously.
Career Highlights
Irfan Baig is currently employed at Alcala Pharmaceutical, Inc., where he applies his expertise in drug analysis and sample preparation. His work is pivotal in advancing methodologies that improve the reliability of drug testing.
Collaborations
Irfan collaborates with notable colleagues, including David J Smith and Matthew D Rifat, who contribute to the innovative environment at Alcala Pharmaceutical, Inc.
Conclusion
Irfan Baig's contributions to the field of drug analysis through his patents and work at Alcala Pharmaceutical, Inc. highlight his role as a key innovator in the industry. His methods not only streamline the testing process but also enhance the accuracy of drug analyte detection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile